NCT02541669View on ClinicalTrials.gov

A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 20, 2015

Primary Completion Date

March 17, 2017

Study Completion Date

March 17, 2017

Conditions
Healthy Volunteer
Interventions
DRUG

TAK-491

TAK-491 tablets

DRUG

TAK-491 placebo

TAK-491 placebo-matching tablets

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY